The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

Yesterday, hearing Martin St-Louis mention the young Russian as a possible option on the first powerplay unit, was intriguing… But apparently, it will have to wait for another day: according to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

"In its first week on sale in the UK, Midnights opened with the biggest first-week sales of Taylor's career at the time, with 204,000 chart units (a record Taylor would break less than two years ...